Sfoglia per AUTORE
MALUCCHI S
Collezione AOU San Luigi di Orbassano

  

Items : 66

Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study. in Journal of neurology / J Neurol. 2024 Jan;271(1):340-354. doi: 10.1007/s00415-023-11955-0. Epub 2023 Sep 16.
2024
AOU San Luigi di Orbassano

Zanetta C; Perini D; Brescia Morra V; Cordioli C; Granella F; Malucchi S; Totaro R; Valente MR; Conte A; Grimaldi L; Filippi M; Santoni L;

SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose. in Journal of neurology / J Neurol. 2024 Jan;271(1):24-31. doi: 10.1007/s00415-023-12034-0. Epub 2023 Nov 3.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Solaro C; Cocco E; Moccia M; Tomassini V; Lanzillo R; Malucchi S; Paolicelli D; De Luca G; Laroni A; Calabrese M; Gajofatto A; Buttari F; Guaschino C; Radaelli M; Fantozzi R; Clerico M; Di Sabatino E; Cavalla P; Nociti V; Lorefice L; Gallo A; Prosperini L; Maniscalco GT; Ragonese P; Ferraro D; Di Filippo M; Gasperini C;

Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2024 Feb;82:105412. doi: 10.1016/j.msard.2023.105412. Epub 2023 Dec 26.
2024
AOU San Luigi di Orbassano

Vecchio D; Puricelli C; Malucchi S; Virgilio E; Martire S; Perga S; Passarelli F; Valentino P; Di Sapio A; Cantello R; Dianzani U; Comi C; Vecchio D; Puricelli C; Malucchi S; Virgilio E; Martire S; Perga S; Passarelli F; Valentino P; Di Sapio A; Cantello R; Dianzani U; Comi C;

2024
AOU San Luigi di Orbassano

Malucchi S; Bava CI; Valentino P; Martire S; Lo Re M; Bertolotto A; Di Sapio A;

Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2024 Aug;88:105748. doi: 10.1016/j.msard.2024.105748. Epub 2024 Jun 29.
2024
AOU San Luigi di Orbassano

Bava CI; Valentino P; Malucchi S; Bottero R; Martire S; Sapio AD; Bertolotto A;

Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Sep;77:104893. doi: 10.1016/j.msard.2023.104893. Epub 2023 Jul 16.
2023
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Bava CI; Martire S; Capobianco M; Malentacchi M; Sperli F; Oggero A; Di Sapio A; Bertolotto A;

Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study. in Journal of neurology / J Neurol. 2023 Oct;270(10):4687-4696. doi: 10.1007/s00415-023-11820-0. Epub 2023 Jul 5.
2023
AOU San Luigi di Orbassano

Amato MP; Bergamaschi R; Centonze D; Mirabella M; Marfia GA; Totaro R; Lus G; Brescia Morra V; Aguglia U; Comi C; Cavalla P; Zaffaroni M; Rovaris M; Grimaldi LM; Leoni S; Malucchi S; Baldi E; Romano M; Falcini M; Perini P; Assetta M; Portaccio E; Sommacal S; Olivieri N; Parodi F; Todaro DS; Grassivaro N; Farina A; Mondino MM; et alii...

Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Feb;70:104474. doi: 10.1016/j.msard.2022.104474. Epub 2022 Dec 19.
2023
AOU San Luigi di Orbassano

Patti F; Chisari CG; Toscano S; Annovazzi P; Banfi P; Bergamaschi R; Clerici R; Conti MZ; Cortese A; Fantozzi R; Ferraro D; Fischetti M; Frigo M; Gatto M; Immovilli P; Leoni S; Malucchi S; Maniscalco G; Marfia GA; Paolicelli D; Perini P; Serrati C; Totaro R; Turano G; Valentino P; Zaffaroni M; Zuliani C; Centonze D; Patti F; et alii...

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Capobianco MA; Pautasso M; Bertolotto A; Valentino P; Martire S; Sala A; Sperli F; Malentacchi M; Malucchi S; Bruschi N;

Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657.
2022
AOU San Luigi di Orbassano

Landi D; Bovis F; Grimaldi A; Annovazzi PO; Bertolotto A; Bianchi A; Borriello G; Brescia Morra V; Bucello S; Buscarinu MC; Caleri F; Capobianco M; Capra R; Cellerino M; Centonze D; Cerqua R; Chisari CG; Clerico M; Cocco E; Cola G; Cordioli C; Curti E; d'Ambrosio A; D'Amico E; De Luca G; Di Filippo M; Di Lemme S; Fantozzi R; Ferraro D; et alii...

sNFL applicability as additional monitoring tool in natalizumab extended interval dosing regimen for RRMS patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2022 Nov;67:104176. doi: 10.1016/j.msard.2022.104176. Epub 2022 Sep 14.
2022
AOU San Luigi di Orbassano

Valentino P; Malucchi S; Martire S; Bava CI; Capobianco MA; Bertolotto A;

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration. in Journal of neurology / J Neurol. 2022 Mar;269(3):1463-1469. doi: 10.1007/s00415-021-10708-1. Epub 2021 Jul 22.
2022
AOU San Luigi di Orbassano

Vitetta F; Pisano E; Malucchi S; Cavalla P; Cellerino M; Patti F; Lus G; Mirabella M; Zaffaroni M; Brescia Morra V; Capobianco M; Inglese M; Guerra T; Iaffaldano P; Ferraro D; Paolicelli D; Sola P; Trojano M;

Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Trojano M; Amato MP; Filippi M; Battaglia MA; Comi G; Tedeschi G; Ponzio M; Mosconi P; Lepore V; Ferraro D; Moiola L; Petracca M; Malucchi S; Toscano S; Totaro R; Brambilla L; Vianello M; Ragonese P; Granella F; Maniscalco GT; Montepietra S; Cavalla P; Lugaresi A; De Luca G; Lus G; Pesci I; Sola P; Brescia Morra V; Capobianco M; et alii...

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Tortorella C; Cocco E; Gasperini C; Solaro C; Gazzola P; Gallo A; Maniscalco GT; Paolicelli D; Calabrese M; Borrelli A; Tomassini V; De Luca G; Clerico M; Boffa L; Lanzillo R; Moccia M; Ferraro D; Gajofatto A; Prosperini L; Fantozzi R; Buttari F; Laroni A; Lorefice L; Radaelli M; Nociti V; Torri Clerici V; Cavalla P; Annovazzi P; Malucchi S; et alii...

Serum neurofilament light chain levels in healthy individuals: A proposal of cut-off values for use in multiple sclerosis clinical practice. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2021 Sep;54:103090. doi: 10.1016/j.msard.2021.103090. Epub 2021 Jun 17.
2021
AOU San Luigi di Orbassano

Valentino P; Marnetto F; Martire S; Malucchi S; Bava CI; Popovic M; Bertolotto A;

Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2021 May;42(Suppl 1):25-28. doi: 10.1007/s10072-020-05027-8. Epub 2021 Mar 12.
2021
AOU San Luigi di Orbassano

Capobianco M; Bertolotto A; Malucchi S;

Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2020 Oct;26(12):1519-1531. doi: 10.1177/1352458519872889. Epub 2019 Oct 1.
2020
ASL Cuneo 1
AOU San Luigi di Orbassano

Gobbi C; Uccelli A; Signori A; Amato MP; Granella F; Barilaro A; Abbadessa G; Fenu G; Brescia Morra V; Prestipino E; Sperli F; Magnani E; Lorefice L; De Angelis M; Malentacchi M; Cellerino M; Gallo A; Sacco R; Mechi C; Salemi G; Coghe G; Nozzolillo A; Malucchi S; Boffa G; Maraffi I; Maietta I; Barone S; Maniscalco GT; Di Sapio A; et alii...

Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2020 Jul;42:102124. doi: 10.1016/j.msard.2020.102124. Epub 2020 Apr 13.
2020
AOU San Luigi di Orbassano

Patti F; Chisari CG; D'Amico E; Annovazzi P; Banfi P; Bergamaschi R; Clerici R; Conti MZ; Cortese A; Fantozzi R; Fischetti M; Frigo M; Gatto M; Immovilli P; Leoni S; Malucchi S; Maniscalco G; Marfia GA; Paolicelli D; Perini P; Serrati C; Sola P; Totaro R; Turano G; Valentino P; Zaffaroni M; Zuliani C; Centonze D;

Informing MS patients on treatment options: a consensus on the process of consent taking. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Aug;41(8):2249-2253. doi: 10.1007/s10072-020-04339-z. Epub 2020 Apr 2.
2020
AOU San Luigi di Orbassano

Tortorella C; Solaro C; Annovazzi P; Boffa L; Buscarinu MC; Buttari F; Calabrese M; Cavalla P; Cocco E; Cordioli C; De Luca G; Di Filippo M; Fantozzi R; Ferraro D; Gajofatto A; Gallo A; Lanzillo R; Laroni A; Fermo SL; Malucchi S; Maniscalco GT; Moccia M; Nociti V; Paolicelli D; Pesci I; Prosperini L; Ragonese P; Tomassini V; Clerici VLAT; et alii...

Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4.
2019
AOU San Luigi di Orbassano

Novi G; Bovis F; Capobianco M; Frau J; Mataluni G; Curti E; Zuliani L; Cavalla P; Brambilla L; Annovazzi P; Repice AM; Lanzillo R; Esposito S; Benedetti L; Maietta I; Sica F; Buttari F; Malucchi S; Fenu G; Landi D; Bosa C; Realmuto S; Malentacchi M; Granella F; Signori A; Bonavita S; Uccelli A; Sormani MP;

"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study. in Neurology / Neurology. 2019 May 28;92(22):e2527-e2537. doi: 10.1212/WNL.0000000000007573. Epub 2019 May 1.
2019
AOU San Luigi di Orbassano

Calabrese M; Gasperini C; Tortorella C; Schiavi G; Frisullo G; Ragonese P; Fantozzi R; Prosperini L; Annovazzi P; Cordioli C; Di Filippo M; Ferraro D; Gajofatto A; Malucchi S; Lo Fermo S; De Luca G; Stromillo ML; Cocco E; Gallo A; Paolicelli D; Lanzillo R; Tomassini V; Pesci I; Rodegher ME; Solaro C;

A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study. in Journal of neurology / J Neurol. 2018 May;265(5):1174-1183. doi: 10.1007/s00415-018-8831-x. Epub 2018 Mar 16.
2018
ASL Vercelli
AOU San Luigi di Orbassano

Gajofatto A; Pesci I; Laroni A; Coghe G; Gallo A; Pinardi F; Buscarinu MC; Di Filippo M; Maniscalco GT; Ragonese P; Buttari F; Boffa L; Clerici VT; Malucchi S; Radaelli M; Cavalla P; Annovazzi P; Nociti V; Tortorella C; Fantozzi R; Moccia M; Gasperini C; Prosperini L; Lanzillo R; Calabrese M; Tomassini V; Cocco E; Solaro C;

A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-?1a using RebiSmart™-the FUTURE study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2017 Nov;38(11):1999-2005. doi: 10.1007/s10072-017-3091-6. Epub 2017 Aug 22.
2017
AOU San Luigi di Orbassano

Ghezzi A; Bianchi A; Baroncini D; Bertolotto A; Malucchi S; Bresciamorra V; Lanzillo R; Milani N; Martinelli V; Patti F; Chisari C; Rottoli M; Simone M; Paolicelli D; Visconti A;

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.
2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2017 Aug;181:83-88. doi: 10.1016/j.clim.2017.06.006. Epub 2017 Jun 19.
2017
AOU San Luigi di Orbassano

Spadaro M; Montarolo F; Perga S; Martire S; Brescia F; Malucchi S; Bertolotto A;

The Effectiveness of a Body-Affective Mindfulness Intervention for Multiple Sclerosis Patients with Depressive Symptoms: A Randomized Controlled Clinical Trial. in Frontiers in psychology / Front Psychol. 2017 Nov 30;8:2083. doi: 10.3389/fpsyg.2017.02083. eCollection 2017.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Torta R; Oliva F; Bertolotto A; Malucchi S; Bertino G; Scavelli F; Francone D; Tesio V; Borghi M; Carletto S; Ostacoli L; Carletto S; Tesio V; Borghi M; Francone D; Scavelli F; Bertino G; Malucchi S; Bertolotto A; Oliva F; Torta R; Ostacoli L;

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study. in Expert opinion on drug delivery / Expert Opin Drug Deliv. 2016 Jun;13(6):799-805. doi: 10.1517/17425247.2016.1158161. Epub 2016 Mar 12
2016
AOU San Luigi di Orbassano

Paolicelli D; Cocco E; Di Lecce V; Direnzo V; Moiola L; Lanzillo R; Perini P; Malucchi S; Borriello G; Portaccio E; Panetta V; Fenu G; Sangalli F; Cacciaguerra L; Trojano M;

2016
ASL Torino 3
AOU San Luigi di Orbassano

Oliva F; Bertolotto A; Malucchi S; Cavallo M; Bertino G; Scavelli F; Francone D; Borghi M; Carletto S; Ostacoli L;

Cytokine profiles show heterogeneity of interferon-? response in multiple sclerosis patients. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(2):e202. doi: 10.1212/NXI.0000000000000202. eCollect
2016
AOU San Luigi di Orbassano

Hegen H; Adrianto I; Lessard CJ; Millonig A; Bertolotto A; Comabella M; Giovannoni G; Guger M; Hoelzl M; Khalil M; Fazekas F; Killestein J; Lindberg RL; Malucchi S; Mehling M; Montalban X; Rudzki D; Schautzer F; Sellebjerg F; Sorensen PS; Deisenhammer F; Steinman L; Axtell RC;

2016
AOU San Luigi di Orbassano

Troni W; Melillo F; Bertolotto A; Malucchi S; Capobianco M; Sperli F; Di Sapio A;

Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study. in Frontiers in human neuroscience / Front Hum Neurosci. 2016 Jun 8;10:282. doi: 10.3389/fnhum.2016.00282. eCollection 2016.
2016
AOU San Luigi di Orbassano

Borghi M; Carletto S; Ostacoli L; Scavelli F; Pia L; Pagani M; Bertolotto A; Malucchi S; Signori A; Cavallo M;

2016
AOU San Luigi di Orbassano

Carletto S; Borghi M; Bertino G; Oliva F; Cavallo M; Hofmann A; Zennaro A; Malucchi S; Ostacoli L;

2015
AOU San Luigi di Orbassano

Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;

Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-? Therapy. in Neurology and therapy / Neurol Ther. 2015 Jun;4(1):53-60. doi: 10.1007/s40120-015-0027-z. Epub 2015 Mar 6.
2015
AOU San Luigi di Orbassano

Motuzova Y; Di Sapio A; Capobianco M; Sala A; Marnetto F; Malucchi S; Bertolotto A;

Anti-inflammatory genes associated with multiple sclerosis: a gene expression study. in Journal of neuroimmunology / J Neuroimmunol. 2015 Feb 15;279:75-8. doi: 10.1016/j.jneuroim.2015.01.004. Epub 2015 Jan 21.
2015
AOU San Luigi di Orbassano

Perga S; Montarolo F; Martire S; Berchialla P; Malucchi S; Bertolotto A;

Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers. in Neurology and therapy / Neurol Ther. 2015 Dec;4(2):147-57. doi: 10.1007/s40120-015-0038-9. Epub 2015 Dec 8.
2015
AOU San Luigi di Orbassano

Lo Re M; Capobianco M; Ragonese P; Realmuto S; Malucchi S; Berchialla P; Salemi G; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec
2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;

Monocytes and CD4+ T cells contribution to the under-expression of NR4A2 and TNFAIP3 genes in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2014 Jul 15;272(1-2):99-102. doi: 10.1016/j.jneuroim.2014.04.017. Epub 2014 May 10.
2014
AOU San Luigi di Orbassano

Navone ND; Perga S; Martire S; Berchialla P; Malucchi S; Bertolotto A;

A new neurophysiological approach to assess central motor conduction damage to proximal and distal muscles of lower limbs. in Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology / Clin Neurophysiol. 2014 Jan;125(1):133-41. doi: 10.1016/j.clinph.2013.06.018. Epub 2013 Jul 16.
2014
AOU San Luigi di Orbassano

Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W; Di Sapio A; Bertolotto A; Melillo F; Sperli F; Malucchi S; Troni W;

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Feb;35(2):307-16. doi: 10.1007/s10072-013-1616-1. Epub 2013 Dec 29.
2014
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Amato MP; Capello E; Capra R; Centonze D; Di Ioia M; Gallo A; Grimaldi L; Imberti L; Lugaresi A; Mancinelli C; Marrosu MG; Moiola L; Montanari E; Romano S; Musu L; Paolicelli D; Patti F; Pozzilli C; Rossi S; Salvetti M; Tedeschi G; Tola MR; Trojano M; Zaffaroni M; Malucchi S; Bertolotto A; Capobianco M; et alii...

Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2014 Aug;20(9):1265-8. doi: 10.1177/1352458514521311. Epub 2014 Feb 10.
2014
AOU San Luigi di Orbassano

Frisullo G; Calabrese M; Tortorella C; Paolicelli D; Ragonese P; Annovazzi P; Radaelli M; Malucchi S; Gallo A; Tomassini V; Nociti V; D'Onghia M; Lo Re V; Rodegher M; Solaro C; Gasperini C;

Prevalence and significant determinants of post-traumatic stress disorder in a large sample of patients with multiple sclerosis. in Journal of clinical psychology in medical settings / J Clin Psychol Med Settings. 2013 Jun;20(2):240-6. doi: 10.1007/s10880-012-9323-2.
2013
ASL Torino 3
AOU San Luigi di Orbassano

Carletto S; Borghi M; Cavallo M; Ostacoli L; Rocci E; Zuffranieri M; Malucchi S; Bertolotto A; Zennaro A; Furlan PM; Picci RL;

Presence and significant determinants of cognitive impairment in a large sample of patients with multiple sclerosis. in PloS one / PLoS One. 2013 Jul 29;8(7):e69820. doi: 10.1371/journal.pone.0069820. Print 2013.
2013
ASL Torino 3
AOU San Luigi di Orbassano

Carletto S; Ostacoli L; Zuffranieri M; Cavallo M; Borghi M; Picci RL; Scavelli F; Johnston H; Furlan PM; Bertolotto A; Malucchi S;

Classification of individuals based on ex-vivo glatiramer acetate-induced interferon-? and interleukin-4 response. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2012 Oct;18(10):1484-92. doi: 10.1177/1352458512440349. Epub 2012 May 4.
2012
AOU San Luigi di Orbassano

Gilli F; Navone ND; Valentino P; Granieri L; Perga S; Malucchi S; Bertolotto A;

One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients. in Journal of neurology / J Neurol. 2011 May;258(5):895-903. doi: 10.1007/s00415-010-5844-5. Epub 2010 Dec 12.
2011
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Sala A; Capobianco M; di Sapio A; Granieri L; Bertolotto A;

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis. in Archives of neurology / Arch Neurol. 2011 Jul;68(7):879-88. doi: 10.1001/archneurol.2011.32. Epub 2011 Mar 14.
2011
AOU San Luigi di Orbassano

Gilli F; Navone ND; Perga S; Marnetto F; Caldano M; Capobianco M; Pulizzi A; Malucchi S; Bertolotto A;

Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. in PloS one / PLoS One. 2010 Jan 29;5(1):e8962. doi: 10.1371/journal.pone.0008962.
2010
AOU San Luigi di Orbassano

Gilli F; Lindberg RL; Valentino P; Marnetto F; Malucchi S; Sala A; Capobianco M; di Sapio A; Sperli F; Kappos L; Calogero RA; Bertolotto A;

Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Sep;29 Suppl 2:S227-9. doi: 10.1007/s10072-008-0945-y.
2008
AOU San Luigi di Orbassano

Capobianco M; Rizzo A; Malucchi S; Sperli F; Di Sapio A; Oggero A; Zaffaroni M; Ghezzi A; Bertolotto A;

Predictive markers for response to interferon therapy in patients with multiple sclerosis. in Neurology / Neurology. 2008 Mar 25;70(13 Pt 2):1119-27. doi: 10.1212/01.wnl.0000304040.29080.7b. Epub 2008 Feb 1
2008
AOU San Luigi di Orbassano

Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A;

Acute myeloid leukemia induced by mitoxantrone treatment for aggressive multiple sclerosis. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2008 Jun;29(3):185-7. doi: 10.1007/s10072-008-0934-1. Epub 2008 Jul 9.
2008
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; Ulisciani S; Fava C; Cambrin GR; Avonto L; Saglio G; Bertolotto A;

Expression and regulation of IFNalpha/beta receptor in IFNbeta-treated patients with multiple sclerosis. in Neurology / Neurology. 2008 Dec 9;71(24):1940-7. doi: 10.1212/01.wnl.0000327340.50284.8d. Epub 2008 Oct 29.
2008
AOU San Luigi di Orbassano

Gilli F; Valentino P; Caldano M; Granieri L; Capobianco M; Malucchi S; Sala A; Marnetto F; Bertolotto A;

Anti-interferon-beta neutralising activity is not entirely mediated by antibodies. in Journal of neuroimmunology / J Neuroimmunol. 2007 Dec;192(1-2):198-205. doi: 10.1016/j.jneuroim.2007.09.025. Epub 2007 Oct 22.
2007
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Valentino P; Granieri L; Di Sapio A; Capobianco M; Sala A; Malucchi S; Kappos L; Lindberg RL; Bertolotto A;

Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2007 Aug;28(4):209-11. doi: 10.1007/s10072-007-0823-z. Epub 2007 Aug 10.
2007
AOU San Luigi di Orbassano

Capobianco M; Malucchi S; di Sapio A; Gilli F; Sala A; Bottero R; Marnetto F; Doriguzzi Bozzo C; Bertolotto A;

Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. in Journal of immunological methods / J Immunol Methods. 2007 Apr 10;321(1-2):19-31. doi: 10.1016/j.jim.2006.12.012. Epub 2007 Feb 20.
2007
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F;

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2006 Feb;12(1):47-57. doi: 10.1191/135248506ms1245oa.
2006
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Capobianco M; Bertolotto A;

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. in Journal of neuroimmunology / J Neuroimmunol. 2005 Jan;158(1-2):195-203. doi: 10.1016/j.jneuroim.2004.08.006.
2005
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Caldano M; Sala A; Malucchi S; Di Sapio A; Capobianco M; Bertolotto A;

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2005 Dec;26 Suppl 4:S213-4. doi: 10.1007/s10072-005-0517-3.
2005
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Gilli F; Marnetto F; Caldano M; Sala A; Bertolotto A;

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259.
2004
AOU San Luigi di Orbassano

Bertolotto A; Sala A; Malucchi S; Marnetto F; Caldano M; Di Sapio A; Capobianco M; Gilli F;

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis. in Neurology / Neurology. 2004 Jun 8;62(11):2031-7. doi: 10.1212/01.wnl.0000129265.73259.9e.
2004
AOU San Luigi di Orbassano

Malucchi S; Sala A; Gilli F; Bottero R; Di Sapio A; Capobianco M; Bertolotto A;

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis. in Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology / Mol Diagn. 2004;8(3):185-94. doi: 10.1007/BF03260063.
2004
AOU San Luigi di Orbassano

Gilli F; Marnetto F; Stefanuto G; Rinaldi V; Farinazzo F; Malucchi S; Capobianco M; Caldano M; Sala A; Bertolotto A;

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2003 Oct;24(3):130-3. doi: 10.1007/s10072-003-0098-y.
2003
AOU San Luigi di Orbassano

Milano E; Di Sapio A; Malucchi S; Capobianco M; Bottero R; Sala A; Gilli F; Bertolotto A;

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients. in Neurology / Neurology. 2003 Feb 25;60(4):634-9. doi: 10.1212/01.wnl.0000046662.03894.c5.
2003
AOU San Luigi di Orbassano

Bertolotto A; Gilli F; Sala A; Capobianco M; Malucchi S; Milano E; Melis F; Marnetto F; Lindberg RL; Bottero R; Di Sapio A; Giordana MT;

Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):148-53. doi: 10.1136/jnnp.73.2.148.
2002
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Sala A; Orefice G; Carrieri PB; Capobianco M; Milano E; Melis F; Giordana MT;

Interferon beta neutralizing antibodies in multiple sclerosis: neutralizing activity and cross-reactivity with three different preparations. in Immunopharmacology / Immunopharmacology. 2000 Jul 20;48(2):95-100. doi: 10.1016/s0162-3109(00)00182-x.
2000
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Milano E; Castello A; Capobianco M; Mutani R;

Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients. in Neuroscience letters / Neurosci Lett. 1999 Mar 19;263(1):21-4. doi: 10.1016/s0304-3940(99)00102-0.
1999
AOU San Luigi di Orbassano

Bertolotto A; Capobianco M; Malucchi S; Manzardo E; Audano L; Bergui M; Bradac GB; Mutani R;

Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses. in Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research / J Interferon Cytokine Res. 1999 Jun;19(6):575-81. doi: 10.1089/107999099313703.
1999
AOU San Luigi di Orbassano

Bertolotto A; Malucchi S; Capobianco M; Manzardo E; Guastamacchia G; Milano E; Audano L; Mutani R;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte